ENT Devices Market Report 2015 - Global Forecast to 2020 - Growing Adoption of Minimally Invasive ENT Procedures

DUBLIN, December 18, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/zkgkrl/ent_devices) has announced the addition of the "ENT Devices Market by Product, Surgical, & End User - Global Forecast to 2020" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769  )

The ENT devices market is poised to reach USD 14,001.3 million by 2020 from USD 10,219.3 million in 2015, growing at a CAGR of 6.5% from 2015 to 2020. This market is categorized on the basis of products, end users, and regions. 

Market growth is driven by the high prevalence of chronic sinusitis, rising geriatric population, favorable reimbursement scenario for ENT procedures in developed countries, rising adoption of minimally invasive ENT procedures, increasing presence of prominent players in the ENT devices market, and technological advancements. However, changes in the reimbursement policy for Tracheoesophageal Voice Prosthesis (TEP) devices in the U.S., high cost of CO2 lasers, and high cost and lack of reimbursement for hearing aids are factors that are likely to restrict the growth of this market. 

The ENT devices market in this report is segmented on the basis of products, end users, and regions. Based on product, the market is segmented into diagnostic devices, surgical devices, hearing aids, hearing implants, CO2 lasers, and image-guided surgery systems. Hearing aids are expected to account for the largest share of market in 2015. The hearing implants segment is slated to grow at a highest CAGR during the forecast period. The high growth in this segment is attributed to the high prevalence of hearing loss, growing geriatric population, rising number of product approvals, and technological advancements. 

The diagnostic devices market is segmented into endoscopes and hearing screening devices. In 2015, the endoscopes segment is estimated to command the largest share of the diagnostic devices market. This segment is expected to continue to dominate the market and grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing number of minimally invasive surgical procedures performed across the globe and introduction of technologically advanced products. 

The surgical devices market is classified into powered surgical instruments, radiofrequency devices, handheld instruments, balloon sinus dilation devices, ENT supplies, ear tubes, and voice prosthesis devices. In 2015, the handheld instruments segment is expected to hold the largest market share and is expected to continue to dominate the surgical devices market during the forecast period. 

The market by end user is segmented into home-use, hospitals, ambulatory settings, and ENT clinics. The ambulatory settings segment is expected to grow at the highest CAGR during the forecast period. 

Key Topics Covered: 

1 Introduction 

2 Research Methodology

3 Executive Summary 

4 Premium Insights 

5 Market Overview 

6 ENT Devices Market, By Product 

7 ENT Devices Market, By End User 

8 ENT Devices Market, By Region 

9 Competitive Landscape 

10 Company Profiles

- Acclarent, Inc. (A Subsidiary of Johnson & Johnson) 
- Cochlear Limited 
- Hoya Corporation 
- Karl Storz Gmbh & Co. Kg 
- Medtronic PLC 
- Olympus Corporation 
- Smith & Nephew PLC 
- Sonova Holding AG 
- Stryker Corporation 
- William Demant Holding A/S 

For more information visit http://www.researchandmarkets.com/research/zkgkrl/ent_devices

Research and Markets: 

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Laura Wood
+353-1-481-1716
[email protected]

SOURCE Research and Markets